SCOPUS 정보 검색 플랫폼

Journal of Pharmacy Practice

Volumn 24, Issue 5, 2011, Pages 439-446

Interpreting and applying CYP450 genomic test results to psychotropic medications

(1) Caley, Charles F a,b

a UNIVERSITY OF CONNECTICUT (United States)

b INSTITUTE OF LIVING (United States)

Author keywords

allele; CYP450; gene; genotype; metabolism; psychotropic

Indexed keywords

ALPRAZOLAM; AMFEBUTAMONE; ANXIOLYTIC AGENT; ATOMOXETINE; BENZATROPINE; BUSPIRONE; CLONAZEPAM; CLONIDINE; CYTOCHROME P450; CYTOCHROME P450 1A2; CYTOCHROME P450 2B6; CYTOCHROME P450 2C19; CYTOCHROME P450 2C9; CYTOCHROME P450 2D6; CYTOCHROME P450 3A4; DEXAMPHETAMINE; DIAZEPAM; DRUG METABOLIZING ENZYME; DULOXETINE; GUANFACINE; HYPNOTIC AGENT; LORAZEPAM; METHYLPHENIDATE; MODAFINIL; MOOD STABILIZER; NEUROLEPTIC AGENT; NOOTROPIC AGENT; PROPRANOLOL; PSYCHOTROPIC AGENT; UNINDEXED DRUG;

ACUTE DEPRESSION; ARTICLE; ATTENTION DEFICIT DISORDER; DEPRESSION; DRUG METABOLISM; DRUG TOLERABILITY; GENETIC POLYMORPHISM; GENOME ANALYSIS; HUMAN; INHERITANCE; MAJOR DEPRESSION; MENTAL DISEASE; PATIENT CARE; PHARMACIST; PHARMACOGENOMICS; TREATMENT DURATION; TREATMENT RESPONSE;

EID: 83455255511 PISSN: 08971900 EISSN: 15311937 Source Type: Journal
DOI: 10.1177/0897190011422873 Document Type: Article

Times cited : (8)

References (8)

1
- 0037068964
- Clinical importance of the cytochromes P450
- DOI 10.1016/S0140-6736(02)11203-7
- Nebert DW, Russell DW.. Clinical importance of the cytochromes P450. Lancet. 2002 ; 360: 1155-1162 (Pubitemid 35246494)
- (2002) Lancet , vol.360 , Issue.9340 , pp. 1155-1162
- Nebert, D.W.¹ Russell, D.W.²

2
- 19444376971
- Drug metabolism and variability among patients in drug response
- Wilkinson GR.. Drug metabolism and variability among patients in drug response. N Engl J Med. 2005 ; 352: 2211-2221
- (2005) N Engl J Med , vol.352 , pp. 2211-2221
- Wilkinson, G.R.¹

3
- 55049100842
- Inhibition and induction of human cytochrome P450 enzymes: Current status
- Pelkonen O, Turpeinen M, Hakkola J, et al. Inhibition and induction of human cytochrome P450 enzymes: current status. Arch Toxicol. 2008 ; 82: 667-715
- (2008) Arch Toxicol , vol.82 , pp. 667-715
- Pelkonen, O.¹ Turpeinen, M.² Hakkola, J.³

4
- 34250325137
- The impact of CYP allelic variation on antidepressant metabolism: A review
- DOI 10.1517/17425255.3.1.21
- Black JL, O'Kane DJ, Mrazek DA.. The impact of CYP allelic variation on antidepressant metabolism: a review. Expert Opin Drug Metab Toxicol. 2007 ; 3 (1). 21-31 (Pubitemid 47307454)
- (2007) Expert Opinion on Drug Metabolism and Toxicology , vol.3 , Issue.1 , pp. 21-31
- Black III, J.L.¹ O'Kane, D.J.² Mrazek, D.A.³

5
- 34548228302
- Amplichip for cytochrome P450 genotyping: The epoch of personalized prescriptions
- Gates BJ, Davies NM.. Amplichip for cytochrome P450 genotyping: the epoch of personalized prescriptions. Hosp Pharm. 2006 ; 41 (5). 442-454
- (2006) Hosp Pharm , vol.41 , Issue.5 , pp. 442-454
- Gates, B.J.¹ Davies, N.M.²

6
- 84855228262
- permission to publish the sample report received from Genomas) Accessed April 9
- Genomas Laboratory of Personalized Health (HILOmet PhyzioTypeTM)www. genomas.net/lph/sample-lph.php(permission to publish the sample report received from Genomas) Accessed April 9, 2010..
- (2010) Genomas Laboratory of Personalized Health (HILOmet PhyzioTypeTM)

7
- 84855249266
- April 12
- Genelex (DNA Drug Sensitivity TestingTM)www.healthanddna.com/drug-safety- dna-testing/sample-reports.htmlAccessed April 12, 2010..
- (2010) Genelex (DNA Drug Sensitivity TestingTM)

8
- 84855233302
- (permission to publish the sample report received from the company). Accessed April 12, 2010
- Genova Diagnostics (DetoxiGenomic Profile)www.gdx.net/product/ 10038(permission to publish the sample report received from the company). Accessed April 12, 2010.
- Genova Diagnostics (DetoxiGenomic Profile)

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.